top of page

HEK293 Human mGluR5 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0153A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


mGluR5 is a widely expressed metabotropic glutamate receptor in the central nervous system. It is primarily located on the surface of neurons, where it regulates synaptic plasticity and neurotransmission to participate in key physiological processes such as learning and memory. It also serves as an important target for drug development in neurological disorders including Fragile X syndrome, Parkinson's disease, anxiety, and pain. Currently, both positive and negative allosteric modulators targeting this receptor have become a research focus for therapeutic strategies.

 

Screeningbio’s HEK293/Human mGluR5 cell line overexpress mGluR5 and is designed to detect increases in intracellular Calcium flux signal in response to agonist stimulation of the receptor. Molecular Devices Calcium 6 kit can be used to detect the signal. 


Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

mGluR5

Accession Number

NM000842

Parental Line

HEK293

Lot#

See Vial

Storage

Liquid Nitrogen


Data

HEK293/human mGluR5 Agonist Assay. HEK293/human mGluR5 cells were treated with the reference agonist L-Glu. The assay was run based on FLIPR Calcium 6 Assay protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
HEK293/human mGluR5 Agonist Assay. HEK293/human mGluR5 cells were treated with the reference agonist L-Glu. The assay was run based on FLIPR Calcium 6 Assay protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.



Target Background


mGluR5 is a widely expressed metabotropic glutamate receptor in the central nervous system. It is primarily located on the surface of neurons, where it regulates synaptic plasticity and neurotransmission to participate in key physiological processes such as learning and memory.


It also serves as an important target for drug development in neurological disorders including Fragile X syndrome, Parkinson's disease, anxiety, and pain. Currently, both positive and negative allosteric modulators targeting this receptor have become a research focus for therapeutic strategies.

Product Documentation



bottom of page